Volume 48

Published on August 2024

Volume title: Proceedings of the Climate Change and Emerging Health Threats: Navigating the Future of Public Health - ICEGEE 2024

Conference website: https://www.icegee.org/
ISBN:978-1-83558-599-3(Print) / 978-1-83558-600-6(Online)
Conference date: 31 May 2024
Editor:Alan Wang
Research Article
Published on 14 August 2024 DOI: 10.54254/2753-8818/48/2024PJ0114
Yuyang Ye
DOI: 10.54254/2753-8818/48/2024PJ0114

Over the period from 2020 to 2023, a four-year non-military battle drew to a close, marking the end of the COVID-19 pandemic that will be etched into history. During this time frame, policies and technologies aimed at combating the virus were developed, ultimately saving numerous lives and enhancing people's efficacy in battling the virus while demonstrating unwavering determination. However, some less mature biological nucleic acid technologies and some controversial policy bases are still being improved. Through the development of biotechnology levels and policies, the research and development of three mRNA vaccines, health codes and RT-PCR nucleic acid detection methods have greatly improved the efficiency of epidemic prevention and control. The government's policy of controlling speech and behavior at the initial stage of the outbreak brought people together to fight against the virus. These technologies are being researched to reduce the number of casualties and minimize losses. For example, circRNA or saRNA vaccines are still in the research stage. If these more advanced techniques are put into use, it will undoubtedly greatly increase the means of fighting against the virus. This is also the direction and key for future research and development.

Show more
View pdf
Ye,Y. (2024).Biotechnology and crisis management developments during the COVID-19 pandemic: Comprehensive analysis.Theoretical and Natural Science,48,1-8.
Export citation
Research Article
Published on 14 August 2024 DOI: 10.54254/2753-8818/48/2024PJ0105
Jiayi Sun
DOI: 10.54254/2753-8818/48/2024PJ0105

Anorexia nervosa, as a psychiatric disorder with a progressively high prevalence, is characterized by the following features: high mortality rate, serious harm, long-lasting effects, difficult to cure and easy to relapse. In recent years, Awareness of anorexia nervosa is different than in the past, going deeper: it is a complex disorder involving multiple systems. Many disciplines are also actively exploring it. However, there are still problems such as Pathologic mechanism unclear, no clear indicators of disease, no targeted drugs, and insufficient public awareness. This article analyses research in the fields of social environment, immunology and brain science in the order of disease onset, evolution and treatment (including difficulties in the treatment process, such as in Refeeding syndrome), and puts forward some recommendations for earlier intervention, comprehensive treatment, and optimization and maintenance of therapeutic efficacy in anorexia nervosa. It is also hoped that public awareness and attention will be raised. There are still many gaps in the road to overcoming anorexia nervosa, which has a large research space and is also not less challenging. Future research could focus on finding objective indicators for diagnosing anorexia nervosa or suggesting recovery, and finding targeted drugs from the perspective of multi-system interactions.

Show more
View pdf
Sun,J. (2024).Anorexia nervosa: Disease process, challenges and hope.Theoretical and Natural Science,48,9-14.
Export citation
Research Article
Published on 14 August 2024 DOI: 10.54254/2753-8818/48/2024PJ0111
Weibo Liu
DOI: 10.54254/2753-8818/48/2024PJ0111

This study explored the globally prevalent pathogens, hepatitis viruses, and their significant impact on human health. This article mainly focuses on HAV, HBV, and HCV, aiming to provide a comprehensive reference for future studies. HAV is mainly transmitted through the gastrointestinal tract, while HBV and HCV are mainly transmitted through blood, body fluids, sexual contact, and mother-to-child transmission. Pathologically, HAV is mostly acute, while HBV and HCV tend to be chronic, which can easily lead to cirrhosis and even liver cancer. Analyzing the transmission mechanism and pathological changes of HAV, HBV, and HCV is crucial for preventing and controlling viral transmission, accurate diagnosis and treatment, formulating public health policies, and public health education. Understanding this information will help reduce the prevalence of hepatitis, improve treatment outcomes, and promote public health. However, the analysis of the structure of these viruses in existing studies is not sufficient. Future studies will further deepen the understanding of HAV, HBV, and HCV, promote vaccine and treatment innovation, and provide stronger support for the prevention and treatment of hepatitis.

Show more
View pdf
Liu,W. (2024).The transmission route of hepatitis A, B, and C virus and its pathological changes on the liver.Theoretical and Natural Science,48,15-21.
Export citation
Research Article
Published on 14 August 2024 DOI: 10.54254/2753-8818/48/2024PJ0117
Hexuan Feng
DOI: 10.54254/2753-8818/48/2024PJ0117

As cancer has gradually become the world's deadliest long-term disease, the impact on the public health has been devastating. Especially the Melanoma which is a cancer with a very high malignant and a high fatality rate. With the emergence of adoptive cell therapy(ACT) based on T Cell Receptor-Gene Engineered T Cells (TCR-T), good results have been obtained in scientific research and clinical fields for a variety of malignant tumors. As TCR-T continues to enter the clinic, the FDA also has approved the first case of TCR-T in 2022, and more and more basic researches and clinical trial projects based on TCR-T are gradually being carried out. However, TCR-T therapy still has some defects, such as non-tumor tissue damage caused by off-target effect and insufficient affinity with tumor tissue. Therefore, the affinity and anti-tumor effectiveness of TCR-T should be improved in multiple aspects, and multi-field cooperation should be carried out to promote the development of basic research, a number of products should be introduced into the clinic, and the intervention of economic means to improve the accessibility of TCR-T. Not only brings the Gospel of cure to patients in the field of solid tumors, but also produces innovation in the field of non-solid tumors.

Show more
View pdf
Feng,H. (2024).Application and development of TCR-T in tumor therapy .Theoretical and Natural Science,48,22-27.
Export citation
Research Article
Published on 14 August 2024 DOI: 10.54254/2753-8818/48/2024PJ0122
Kai Wang
DOI: 10.54254/2753-8818/48/2024PJ0122

Following the COVID-19 outbreak, two mRNA vaccines were marketed in late 2020 after receiving FDA-approved emergency access, pioneering the use of mRNA vaccines in humans. Since then, more and more companies have joined the development and clinical trials of mRNA vaccines. At this stage, the development of mRNA vaccines is not only limited to COVID-19, but also covers infectious diseases, influenza, and cancer. Up to now, the regulation of immunogenicity of mRNA vaccines is a problem to be solved, and the controversy is mainly about typeⅠIFN. This paper mainly introduces the classification, mechanism and characteristics of mRNA vaccines to show the basic principle of mRNA vaccines, and lists the applications of mRNA vaccines and the types of vaccines that are undergoing clinical trials, which reflects their huge application potential. The potential of mRNA vaccines is shown. With this paper, the author summarizes the current status of mRNA vaccines in order to show readers the basic principles and potentials of mRNA vaccines.

Show more
View pdf
Wang,K. (2024).Mechanism of mRNA vaccine, current study and direction of development.Theoretical and Natural Science,48,28-33.
Export citation
Research Article
Published on 14 August 2024 DOI: 10.54254/2753-8818/48/2024PJ0125
Angela J. Tan
DOI: 10.54254/2753-8818/48/2024PJ0125

Considering the unsuccessful results and lack of sustainable efficiency of previous cancer therapies, T-immunotherapy's clinical success has led to a revolution in cancer treatments. Blood cancers, characterized by abnormal blood cells and metastasis, result in severe health issues and cause high mortality rates. Conventional treatments like chemotherapy and radiation often result in poor prognoses due to cancer cell resistance and have a high relapse rate. This paper focuses on how Chimeric Antigen Receptor (CAR)-T cell therapy removes tumor cancerous cells with genetically engineered T-cells. The specific targeting ability of T-cell allows it to overcome the difficulty unresolved by traditional treatments. Despite its significant progress, CAR-T cell therapy also experienced new challenges brought by its specific treatment: cytokine release syndrome and logistical complexities. This paper provides a comprehensive review of T-cell therapy's novel enhancement of blood cancers, including its mechanisms, applications, and side effects after therapy. Various data underline T-cell therapy's potential as a novel cancer treatment, though further research is needed to address its limitations and improve patient outcomes. This research paper provides valuable insights into CAR-T therapy application, minimizing toxicity, and expanding its applicability, offering a reference for future research. Unresolved issues such as managing side effects and improving accessibility continue to be focused for future investigation.

Show more
View pdf
Tan,A.J. (2024).Car-T cell therapy: T-immunotherapy application in blood cancer.Theoretical and Natural Science,48,34-39.
Export citation
Research Article
Published on 31 August 2024 DOI: 10.54254/2753-8818/48/2024PJ0130
Guangrui Guan
DOI: 10.54254/2753-8818/48/2024PJ0130

Population aging is a significant medical and sociodemographic issue facing the world today. While the financial circumstances of older adults have seen some progress in recent decades, a significant number of senior citizens in the United States still grapple with the challenges of affording daily necessities and encounter inadequacies in their health insurance coverage. Current research has explored the challenges in elderly care, including shortages of medical staff and the need for integrating medical care with nursing care. However, there is still a lack of comprehensive policy approaches to address these issues. This article analyzes the current landscape of elderly care policies and proposes strategies to improve the independence and caregiving abilities of older people. The key findings suggest that increasing fertility rates through government policies and promoting the integration of nursing and medical care can significantly improve the quality of life for the elderly. The proposed "medical care and elderly care" model combines medical treatment with principles of elderly care, offering a more comprehensive approach to meet the health and well-being needs of older adults. The insights from this article provide valuable references for future policymaking and research in elderly care. However, further studies are needed to explore the implementation and effectiveness of these proposed strategies in various contexts. Future research should also focus on developing innovative solutions to address the growing challenges in elderly care as the global population continues to age.

Show more
View pdf
Guan,G. (2024).Advances in public health strategies: Addressing elderly care policies.Theoretical and Natural Science,48,40-44.
Export citation
Research Article
Published on 31 August 2024 DOI: 10.54254/2753-8818/48/2024PJ0121
Jinghao Guan
DOI: 10.54254/2753-8818/48/2024PJ0121

This paper explores the complex relationship between aging and inflammation and its impact on the development of chronic diseases. Aging is an important contributor to elevated levels of inflammation, with mechanisms including changes in immune regulatory function, chronic low-grade inflammation, cellular aging and tissue damage, changes in gene expression, and increased oxidative stress. These inflammatory processes not only accelerate aging itself, but also promote the development of chronic diseases such as cardiovascular disease (CVD) and Alzheimer’s disease (AD). The article goes on to address other modern anti-inflammatory treatment approaches, such as biologics, JAK inhibitors, and nonsteroidal anti-inflammatory medications. These treatments help manage and mitigate aging-related pathologies by targeting key molecules and pathways of inflammation. A better comprehension of the relationship between inflammation and aging may serve as the foundation for the creation of novel therapeutic approaches that, in addition to reducing inflammatory reactions, may also prevent or slow the advancement of illnesses associated with age. This article aims to improve medical and scientific understanding of the relationship between inflammation and aging and to encourage the development and use of more potent therapies to lessen the burden of chronic illnesses and enhance the quality of life for the aged.

Show more
View pdf
Guan,J. (2024).The interplay between aging and inflammation and its role in chronic disease development.Theoretical and Natural Science,48,45-54.
Export citation